Reuters logo
BRIEF-Boston Scientific outlines strategy for sustained growth at 2017 investor day
June 27, 2017 / 11:37 AM / 5 months ago

BRIEF-Boston Scientific outlines strategy for sustained growth at 2017 investor day

June 27 (Reuters) - Boston Scientific Corp

* Boston Scientific outlines strategy for sustained growth at 2017 investor day

* Continues to expect to launch Lotus Edge valve system in Europe and submit U.S. pre-market approval submission in Q4 of 2017

* Company expects to introduce vercise dbs system in U.S. by early 2018, pending regulatory approval

* Goal is to achieve an organic revenue compound annual growth rate for 2018-2020 of six to eight percent

* Goal is to achieve consistent double-digit adjusted EPS growth for 2018-2020

* Five-year growth strategy intended to help reach a 25 percent adjusted operating margin in 2017 and 28 percent in 2020 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below